Here are four points:
1. An increasing number of spinal disorders will boost market growth.
2. Spinal surgery complications will hinder market expansion, though.
3. The report indicates companies will develop more surfaced-modified titanium in spine devices.
4. Dominant market vendors include West Chester, Pa. DePuy Synthes; Dublin, Ireland-based Medtronic; San Digeo-based NuVasive; Kalamazoo, Mich.-based Stryker; and Warsaw, Ind.-based Zimmer Biomet.
More articles on spine:
Physician-owned ASCs driving lumbar spine fusion market; best practices for outpatient cervical spine surgery & more — 8 outpatient spine stories
Behind bars for fraud: Neurosurgeon Dr. Aria Sabit receives nearly 20-year prison sentence — 8 key insights
Multiple-level vs. single-level cervical disc replacement for spondylosis — Which yields better outcomes & safety?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
